Stout has advised QLS Logistics & Transportation (“QLS” or the “Company”) on its sale to Bluejay Capital Partners (“Bluejay Capital”), with Terry Fewless, founder of QLS, retaining a significant ownership stake in the business. Stout served as the exclusive sell-side financial advisor to QLS in connection with the transaction, which closed on November 17, 2025.

Based in Coopersville, Michigan, QLS is a premier independent provider of high-security, temperature-controlled transportation and logistics solutions, serving pharmaceutical and life sciences manufacturers and distributors across North America. With over 20 years of industry expertise, QLS’s leadership has established the industry benchmark for transporting high-value pharmaceutical and biotech products requiring the most stringent levels of temperature control and security through a refined, multi-layered security framework.

Bluejay Capital is an operationally focused private investment firm specializing in transportation and logistics, leveraging the founders’ prior experience as industry operators who have successfully founded, scaled, and exited T&L businesses.

Bluejay Capital financed the transaction with Revelation Partners, the largest secondaries investment manager providing flexible capital solutions to the healthcare ecosystem, with a targeted focus on medical devices, diagnostics, biotech, healthcare technology, and healthcare services.

Honigman LLP served as legal counsel to QLS, McGuireWoods LLP served as legal counsel to Bluejay Capital, and Bass, Berry & Sims PLC served as legal counsel to Revelation Partners.